Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications

Area of Science:

• Cardiology
• Regenerative Medicine
• Diabetology

Background:

• Diabetes mellitus is a significant risk factor for coronary artery disease (CAD).
• Despite advances in treatments like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), morbidity and mortality remain high in CAD patients.
• Stem cell regenerative therapy presents a potential therapeutic avenue for CAD, especially for patients ineligible for revascularization procedures.

Purpose of the Study:

• To evaluate the efficacy of stem cell therapy in patients with coronary artery disease (CAD) and heart failure.
• To explore the mechanisms of stem cell action, including angiogenesis and cardiomyocyte regeneration.
• To compare the effectiveness of different cell types and assess the impact of diabetes mellitus on treatment outcomes.

Main Methods:

• Review of recently published clinical trials and meta-analyses of stem cell studies in CAD patients.
• Analysis of outcomes such as left ventricle ejection fraction and symptom reduction.
• Comparison of efficacy across different stem cell types and patient cohorts, including those with diabetes mellitus.

Main Results:

• Stem cell therapy has demonstrated encouraging results in improving left ventricle ejection fraction and reducing symptoms in patients with CAD and heart failure.
• Mesenchymal stem cells show potential for greater effectiveness compared to other cell types.
• Cell therapy may be particularly beneficial for patients with pre-existing diabetes mellitus.

Conclusions:

• Stem cell regenerative therapy is a promising approach for managing CAD and heart failure.
• Further clinical investigations are warranted to optimize stem cell therapy protocols and confirm its long-term benefits, especially in diabetic populations.
• The findings support continued research into stem cells as a viable treatment option for cardiovascular diseases.